VAREX IMAGING Current Ratio 2015-2018 | VREX
VAREX IMAGING current ratio from 2015 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| VAREX IMAGING Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2018-12-31 | $0.47B | $0.17B | 2.81 |
| 2018-09-30 | $0.46B | $0.15B | 3.01 |
| 2018-06-30 | $0.44B | $0.14B | 3.16 |
| 2018-03-31 | $0.45B | $0.14B | 3.25 |
| 2017-12-31 | $0.48B | $0.15B | 3.25 |
| 2017-09-30 | $0.50B | $0.15B | 3.26 |
| 2017-06-30 | $0.51B | $0.15B | 3.30 |
| 2017-03-31 | $0.43B | $0.15B | 2.91 |
| 2016-12-31 | $0.38B | $0.08B | 4.94 |
| 2016-09-30 | $0.36B | $0.08B | 4.63 |
| 2016-06-30 | $0.00B | $0.00B | 0.00 |
| 2016-03-31 | $0.00B | $0.00B | 0.00 |
| 2015-12-31 | $0.00B | $0.00B | 0.00 |
| 2015-09-30 | $0.32B | $0.08B | 4.02 |
| 2014-09-30 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.299B | $0.773B |
| Varex Imaging Corporation is an innovator, designer and manufacturer of X-ray imaging components which include tubes, digital flat panel detectors and other image processing solutions. Its components are used in medical imaging as well as industrial and security imaging applications. The company operates primarily in North America, Europe and Asia. Varex Imaging Corporation is based in Salt Lake City, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $140.623B | 27.80 |
| Medtronic (MDT) | Ireland | $123.520B | 18.06 |
| Stryker (SYK) | United States | $73.875B | 27.09 |
| Boston Scientific (BSX) | United States | $52.874B | 25.78 |
| Baxter (BAX) | United States | $40.209B | 25.72 |
| Zimmer Biomet Holdings (ZBH) | United States | $26.486B | 16.96 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $17.634B | 0.00 |
| Canopy Growth (CGC) | Canada | $15.407B | 0.00 |
| ResMed (RMD) | United States | $14.469B | 27.44 |
| Aurora Cannabis (ACB) | Canada | $9.687B | 68.36 |
| Bio-Rad Laboratories (BIO) | United States | $9.455B | 53.94 |
| Hill-Rom Holdings (HRC) | United States | $7.140B | 22.08 |
| Perrigo (PRGO) | Ireland | $6.601B | 10.70 |
| Insulet (PODD) | United States | $6.039B | 2037.40 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $5.309B | 0.00 |
| ICU Medical (ICUI) | United States | $4.841B | 30.14 |
| Haemonetics (HAE) | United States | $4.496B | 39.88 |
| Hutchison China MediTech (HCM) | China | $3.961B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $3.830B | 0.00 |
| Neogen (NEOG) | United States | $3.332B | 51.18 |
| NuVasive (NUVA) | United States | $2.927B | 25.53 |
| Quidel (QDEL) | United States | $2.672B | 24.11 |
| Aphria (APHA) | $2.518B | 111.78 | |
| National Vision Holdings (EYE) | United States | $2.327B | 45.77 |
| HEXO (HEXO) | $1.429B | 0.00 | |
| Cardiovascular Systems (CSII) | United States | $1.402B | 1006.25 |
| Phibro Animal Health (PAHC) | United States | $1.308B | 18.80 |
| AtriCure (ATRC) | United States | $1.104B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.968B | 26.15 |
| MacroGenics (MGNX) | United States | $0.967B | 0.00 |
| Cerus (CERS) | United States | $0.885B | 0.00 |
| PetIQ (PETQ) | United States | $0.872B | 24.96 |
| Omeros (OMER) | United States | $0.868B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.753B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $0.727B | 21.67 |
| OraSure Technologies (OSUR) | United States | $0.713B | 31.24 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.705B | 23.99 |
| Evolus (EOLS) | United States | $0.701B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.650B | 0.00 |
| Surmodics (SRDX) | United States | $0.618B | 89.94 |
| LeMaitre Vascular (LMAT) | United States | $0.614B | 29.21 |
| Quanterix (QTRX) | United States | $0.551B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.397B | 163.54 |
| Vapotherm (VAPO) | United States | $0.371B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.363B | 0.00 |
| Insys Therapeutics (INSY) | United States | $0.358B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.312B | 20.30 |
| Owens & Minor (OMI) | United States | $0.284B | 3.94 |
| Bovie Medical (APYX) | United States | $0.264B | 0.00 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.257B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.255B | 0.00 |
| Zynex (ZYXI) | United States | $0.143B | 15.35 |
| Fonar (FONR) | United States | $0.143B | 7.64 |
| Surface Oncology (SURF) | United States | $0.117B | 0.00 |
| Chimerix (CMRX) | United States | $0.102B | 0.00 |
| Female Health (VERU) | United States | $0.100B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.097B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.090B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.088B | 0.00 |
| United-Guardian (UG) | United States | $0.087B | 20.01 |
| CAS Medical Systems (CASM) | United States | $0.071B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.071B | 21.00 |
| Neurotrope (NTRP) | United States | $0.061B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.036B | 0.00 |
| Senestech (SNES) | United States | $0.028B | 0.00 |
| Myomo (MYO) | United States | $0.022B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.018B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.015B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 15.57 |
